Drug intelligence / Profile preview

4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one

Development stage: Unknown
Modality: Small Molecules

Overview

4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one is a small molecule with the chemical formula C17H14N2O2. It is classified as a pharmaceutical compound, though currently, there is no publicly available information regarding its specific mechanism of action, primary indications, or any active clinical trials. The compound has not received approval from major regulatory bodies such as the FDA, EMA, or NMPA. Its development status, developers, and manufacturers are currently unknown.

Other names: DB07151DB-07151DB 07151RefChem:5142584-(4-hydroxy-3-methylphenyl)-6-phenyl-2,5-dihydropyrimidin-2-oneSCHEMBL21067340SCHEMBL-21067340SCHEMBL 210673404-(4-hydroxy-3-methylphenyl)-6-phenyl-5H-pyrimidin-2-one

Beyond the preview

Go deeper on 4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one.

Explore the full profile